Serum proteins as drug carriers of anticancer agents: a review.
about
Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?Fatty acids as therapeutic auxiliaries for oral and parenteral formulationsTherapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.Targeted albumin-based nanoparticles for delivery of amphipathic drugs.Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells.Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes.Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials.Blood-brain barrier transport of therapeutics via receptor-mediationSynthesis and characterization of novel bioactive 1,2,4-oxadiazole natural product analogs bearing the N-phenylmaleimide and N-phenylsuccinimide moietiesInteractive association of drugs binding to human serum albumin.Synthesis and characterization of bovine serum albumin-coated nanocapsules loaded with indocyanine green as potential multifunctional nanoconstructs.Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 CellsStructure-based bioisosterism design, synthesis, insecticidal activity and structure-activity relationship (SAR) of anthranilic diamide analogues containing 1,2,4-oxadiazole rings.Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble camptothecin analog irinotecan hydrochloride.Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets.Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis.Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in Mice.Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin.Catabolism of (64)Cu and Cy5.5-labeled human serum albumin in a tumor xenograft model.
P2860
Q26771133-C2CDFE28-A387-4D91-BDD3-37D8BAAC3CDEQ26828805-1779A4A2-C6B3-4FF4-B554-5C2328A0891FQ34417525-C83FD512-C890-47DC-8486-303E460E324CQ35086678-261E998A-A5F6-4058-84CC-30143F73107FQ35147280-7DF7F039-D6D0-42AF-969F-F9B457B05786Q35598122-5E418C88-CE65-4259-9617-9686F219EB22Q36643541-59449867-EDED-4D7A-8910-B6012392AB28Q36821369-09154C41-BAB8-4C56-B710-A46EF8435F29Q36874295-BDC560B6-F00B-45AE-941C-FD5F5D922E67Q37285467-B588E57B-6731-4608-B843-8B34DFC22CD6Q38192435-8CC6A7C6-1527-4F12-88DB-1EE8D4AC0AA4Q39457209-E7F3A157-100D-4718-BC3D-03F18F97A2D2Q40394908-B42C5EDB-3AA1-4D8B-8EF8-123401F1AE9FQ41807830-39A25FE6-1CD1-4ADB-83F4-9956B6FB7022Q41990808-74747C2A-81A0-4B5C-862D-DC29634FEB88Q46548051-1136202E-BD97-49F2-A7E6-E94603CCE2C5Q46795399-53CA30FA-A3CF-41D8-928E-3368AFD96EC3Q47116787-B7B7EEB9-36BD-4899-B6EE-4F82D93FAABCQ47122678-1753011C-C04C-4098-9474-759450B8827AQ50431829-5B8A6563-4C8B-4041-AFB3-D0AAD5BB1EF0Q51763941-EB3DF32A-FA7E-4FF7-82A1-FDFFB4E80467Q53118142-056F8EBF-1515-46D9-9A47-A16B655091DD
P2860
Serum proteins as drug carriers of anticancer agents: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum proteins as drug carriers of anticancer agents: a review.
@en
Serum proteins as drug carriers of anticancer agents: a review.
@nl
type
label
Serum proteins as drug carriers of anticancer agents: a review.
@en
Serum proteins as drug carriers of anticancer agents: a review.
@nl
prefLabel
Serum proteins as drug carriers of anticancer agents: a review.
@en
Serum proteins as drug carriers of anticancer agents: a review.
@nl
P2860
P1433
P1476
Serum proteins as drug carriers of anticancer agents: a review.
@en
P2860
P304
P356
10.3109/10717549809065759
P407
P577
1998-01-01T00:00:00Z